FDA Approved: RELEUKO — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for RELEUKO (filgrastim) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• RELEUKO (FILGRASTIM)

Snippet

SUPPL AP for RELEUKO (FILGRASTIM)